ArticleFrontiers in pharmacology2022

Myricitrin inhibits fibroblast-like synoviocyte-mediated rheumatoid synovial inflammation and joint destruction by targeting AIM2.

Chuyu Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.